Ivermectin for olfaction disorders

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 7 Mar 2022: Trial registered, NCT05269030

The trials

NCT05269030: Ivermectin Nasal Drops in Post COVID-19 Parosmia

State
State not given
Phase
Phase 2
People
60 planned
Started
Jul 2022
Primary completion
Mar 2023
Arms
Case group
Results
None posted
  1. 7 Mar 2022: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Also known as Acarexx, Bimectin, Bovinet, Cardomec, CARDOTEK 30, Cevamec, Equimec, Eqvalan, Heartgard, Hyvermectin, Ivectin, IVERMECTIN (IVER P®) arm will receive IVM 600 µg / kg once daily plus standard care. CONTROL arm will receive standard care., Ivertin, Ivomec, Ivosint, Ivermectin (IVM), Ivermectin 0.4mg/kg/day for 5 days, Ivermectin 3 MG, Ivermectin 3mg Tab, Ivermectin Injectable Product, Ivermectin Oral Product, Ivermectin Pill, Ivermectin Tablets, Ivermectin Topical, Ivermectin nasal, Ivermectin oral, Jetamec, Mectizan, Noramectin, Noromectin, Oramec, Pandex, Phoenectin, Sklice, Soolantra, Stromectol, Uvemec, Vermic, Vetmec, Zimecterin, intranasal ivermectin spray.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.